These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 13379520)

  • 1. Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin.
    FINLAND M; JONES WF; NICHOLS RL
    Proc Soc Exp Biol Med; 1956 Nov; 93(2):388-93. PubMed ID: 13379520
    [No Abstract]   [Full Text] [Related]  

  • 2. Transduction of resistance to some macrolide antibiotics in Staphylococcus aureus.
    PATTEE PA; BALDWIN JN
    J Bacteriol; 1962 Nov; 84(5):1049-55. PubMed ID: 13941896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin, and spiramycin.
    LOWBURY EJ; HURST L
    J Clin Pathol; 1959 Mar; 12(2):163-9. PubMed ID: 13641436
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of erythromycin with oleandomycin in combination with other antibiotics against hospital staphylococci.
    ELLIOTT HJ; HALL WH
    J Lab Clin Med; 1959 Mar; 53(3):364-75. PubMed ID: 13631321
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of cross resistance to erythromycin and carbomycin in Micrococcus pyogenes var. aureus.
    HSIE JY; KOTZ R; NUSSER W
    Antibiot Annu; 1955-1956; 3():773-7. PubMed ID: 13355361
    [No Abstract]   [Full Text] [Related]  

  • 6. Susceptibility of Proteus mirabilis and its stable L-forms to erythromycin and other macrolides.
    TAUBENECK U
    Nature; 1962 Oct; 196():195-6. PubMed ID: 13993473
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of a combination of sodium sulfisoxazole and oleandomycin phosphate on the development of drug resistance of Micrococcus pyogenes var. aureus in vitro.
    DELORENZO WF
    Antibiot Chemother (Northfield); 1958 Feb; 8(2):84-5. PubMed ID: 24544672
    [No Abstract]   [Full Text] [Related]  

  • 8. Induced resistance of staphylococci to carbomycin and erythromycin.
    RAJAM PC; ADCOCK JD
    Med Bull (Ann Arbor); 1953 Aug; 19(8):212-7. PubMed ID: 13090461
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vitro antagonism between erythromycin and spiramycin].
    CHABBERT Y
    Ann Inst Pasteur (Paris); 1956 Jun; 90(6):787-90. PubMed ID: 13340322
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of vancomycin, oleandomycin, and novobiocin and staphylococci in vitro.
    RANTZ LA; RANDALL E; THUM L; BARKER LF
    Antibiot Chemother (Northfield); 1957 Aug; 7(8):399-409. PubMed ID: 24544513
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of the antistaphylococcal bacteriostatic activity of 4 antibiotics: erythromycin, spiramycin, oleandomycin and novobiocin].
    BURDIN JC; SCHMITT J; de LAVERGNE
    Rev Med Nancy; 1959 Oct; 84():930-3. PubMed ID: 13806021
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibiotic mixtures; in vitro effect of a tetracycline-oleandomycin mixture (PA 775) on staphylococci.
    Levitt RO; Hubble RH
    N Engl J Med; 1957 Jul; 257(4):180-1. PubMed ID: 13452068
    [No Abstract]   [Full Text] [Related]  

  • 13. Origin of erythromycin-resistant strains of Micrococcus pyogenes in infections; bacteriophage types and in vitro resistance of cultures to antibiotics.
    WISE RI; VOIGT AE; COLLIN MV; CRANNY CL
    AMA Arch Intern Med; 1955 Mar; 95(3):419-26. PubMed ID: 14349420
    [No Abstract]   [Full Text] [Related]  

  • 14. Staphylococcal resistance to ristocetin, oleandomycin, and novobiocin.
    HSIE JY; NUSSER W; EPSTEIN S; VAN MAREN H; OZOG S
    Antibiot Chemother (Northfield); 1958 Dec; 8(12):607-14. PubMed ID: 24545054
    [No Abstract]   [Full Text] [Related]  

  • 15. [In vitro activity of spiramycin in combination with tetracycline, erythromycin, penicillin, streptomycin, on Staphylococcus aureus multiplication, studied by microbiophotometer].
    Mathieu N; Faguet M
    Ann Inst Pasteur (Paris); 1958 Jan; 94(1):69-77. PubMed ID: 13509310
    [No Abstract]   [Full Text] [Related]  

  • 16. In-vitro activity of sigmamycin: a combination of tetracycline and oleandomycin.
    FAIRBROTHER RW; SOUTHALL JE
    Lancet; 1957 Nov; 273(7003):974-6. PubMed ID: 13482262
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro sensitivity of erythromycin-resistant strains of staphylococci and enterococci to vancomycin and novobiocin.
    SCHNEIERSON SS; AMSTERDAM D
    Antibiot Chemother (Northfield); 1957 May; 7(5):251-4. PubMed ID: 24544426
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacterial susceptibility to antibiotics. V. Relative susceptibility of staphylococci and enterococci to erythromycin, carbomycin and a combination of chlortetracycline and chloramphenicol.
    EISENBERG GM; FLIPPIN HF; O'LOUGHLIN JM
    Antibiot Chemother (Northfield); 1953 Oct; 3(10):1026-8. PubMed ID: 24542703
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory studies of oleandomycin (matromycin).
    GERACI JE; NEEDHAM GM
    Antibiotic Med Clin Ther (New York); 1956 Oct; 3(5):334-5. PubMed ID: 13363377
    [No Abstract]   [Full Text] [Related]  

  • 20. [Resistance characteristics in hospital material, with special reference to staphylococcic and enterococcic sensitivity to erythromycin].
    KYLIN O
    Sven Lakartidn; 1956 Sep; 53(36):2259-67. PubMed ID: 13360709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.